Health Inequity Has Been Reduced to a ‘Checklist of Unmet Social Needs,’ Exec Says

Healthcare companies are ramping up health equity efforts. However, many are still missing the mark, one executive recently said. “When we talk about health inequity, when we talk about social determinants of health, that’s been reduced to this checklist of unmet social needs,” said Dr. Shreya Kangovi, executive director of the Penn Center for Community … Read more

Clinicians Offer Snapshot from Day in the Life of Delivering Care at Teladoc Health

  Teladoc Health supports whole person care through its virtual primary care solution Primary360, as well as urgent care, chronic condition management, mental health and other specialty care programs.  In a series of interviews, two Teladoc Health physicians and a therapist offered a window into a day in the life of delivering virtual care. Vanessa … Read more

After FDA Miss in Diabetes, Lexicon Lands Long-Awaited Approval in Heart Failure

A Lexicon Pharmaceuticals drug that failed to secure FDA approval in type 1 diabetes under a partnership with Sanofi is now approved as a heart failure therapy. The regulatory nod puts the Lexicon pill in competition with medicines marketed by AstraZeneca and partners Eli Lilly and Boehringer Ingelheim. Approval of the drug, sotagliflozin, covers adults … Read more

In Therapeutic Innovation, Digital Must Be Held to the Same Rigor as Biotech

In the last few decades, we’ve watched as innovations from antibodies to gene therapy, and from CAR-T to CRISPR have been advanced by biotechnicians and life scientists. These technological advancements are welcomed both by those who seek healing and those who seek to heal, as they explore all possible options to improve life and restore … Read more

Retailers Are Making a Big Push Into Healthcare. Is Our Sector Ready?

The trend of brand-name retailers growing their presence in healthcare continues to build. In the past couple of years Amazon, CVS Health, and Walgreens have spent billions of dollars in acquisitions to stake their claim. From primary and specialty care to home health and retail health, these companies are betting on putting their years of … Read more

Where Cell Therapies Are Going Next, and How Insurers Are Getting Ready

Cell therapy brings a new dimension to the personalization of cancer care. These treatments are currently made by engineering a patient’s own immune cells into better and more targeted cancer fighters. Since these CAR T-therapies were first approved in 2017, the biopharmaceutical industry has been working to improve how these living medicines are manufactured. Six … Read more

Commercial Payers’ Rising Claims Denials Rates Are Exacerbating Hospitals’ Financial Woes

It’s no secret that hospitals and health systems have been facing severe financial woes in the past couple years. These money problems have forced many providers to make what they likely felt were tough but necessary choices — such as shuttering underperforming service lines, laying off staff and using debt collection agencies to obtain payment … Read more

A Father’s Vision for New Kind of Gene Therapy Leads to a $100M Financing

When it comes to the health and wellbeing of a child, parents will do just about anything. Paul Bresge started a biotech company. Bresge’s middle daughter, Tamar, was young when her eye problems started. She describes her vision as a tunnel that slowly gets tighter. At 15, she was diagnosed with retinitis pigmentosa, a rare … Read more

Survey: 65% of Americans Say Employer-sponsored Insurance Necessary for Financial Security

About 65% of Americans believe that employer-sponsored insurance provides them with “financial peace of mind,” a new survey shows. The AHIP report, published Wednesday, was conducted by Locust Street Group from April 17 to April 25 as part of AHIP’s Coverage@Work campaign, which aims to gather insights on Americans’ thoughts on employer-sponsored coverage. It included … Read more

Health Investors’ Benchmarks Have Moved in Current Fundraising Environment, Exec Says

Fundraising is always difficult, but perhaps especially so in today’s economic climate. In response, health investors are taking their time in their investments. “Right now, what we’re seeing is the benchmarks have moved for what investors are looking for, and rounds are taking a lot longer to close,” said Ulili Onovakpuri, managing partner of Kapor … Read more